AzTrials
AzTrials

To Study the Effects of Protein Supplements on Blood TestsNCT04170036

Do High Doses of Protein Supplements Affect Serum Lipid Profiles?

An observational study of To Study the Effects of Protein Supplements on Blood Tests, run by Near East University, Turkey at 1 site in Cyprus.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Protein supplements are widely used among people going to the gym. The effects of these substances on blood biochemical, hematological, inflammatuary, glucose metabolism markers and lipid profile is not well known. The previous studies on this issue give inconclusive results. Read more about this study

Who is it for?
Ages 18 to 45 years, men onlyHealthy volunteers can take part
What is being tested?
protein supplement
How many people
69 participants
Where
1 siteCyprus
Study dates
15 Mar 2019to 20 Aug 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Study population: Healthy population going to the gym for at least three preceding months

Who may be able to join

  • Going to the gym for at least three preceding months

Who cannot join

  • Any kind of acute or chronic illness
  • Abnormality on electrocardiography
  • Body-mass index>30 kg/m2
  • Use of any kind of drugs
  • Hypertension at the time of recruitment

Trial locations and contacts

1 site in 1 country.

Cyprus1 site
  • Near East University

    Nicosia, 99138

Other trials in Cyprus

About this study

Protein supplements are widely used among people going to the gym. The effects of these substances on blood biochemical, hematological, inflammatuary, glucose metabolism markers and lipid profile is not well known. The previous studies on this issue give inconclusive results. So the investigators aimed to investigate this subject and compare the blood tests between subjects using and not using protein supplements.

Read the detailed description

As more people are doing regular exercises, people using protein supplements are also increasing. The effects of these substances on blood lipid profiles, biochemical, hematological parameters, inflammatory and glucose metabolism markers are not well known. So the investigators of this study planned to search the effects of these substances on blood tests. Totally 69 subjects going to the gym for at least three preceding months were included to the study. They were divided into two groups: the ones using protein supplements and the ones who never used these substances. Demographic and clinical characteristics were recorded. Dietician assessed the dietary habits of the subjects. Blood was drawn for the tests mentioned above from all of the subjects. And the results were compared between the two groups.

Being tested
protein supplement
Keywords
Protein supplement, Serum creatinine, Serum sodium, Glucose metabolism, Lipid profile, C-reactive protein

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • protein supplementDietary supplement

    Protein supplement usage for at least three preceding months in varied amounts

Study groups in NCT04170036
Study groupRoleWhat they receive
Protein supplement groupThe group of subjects who use protein supplements at least for the preceding three months
Receives: Dietary Supplement: protein supplement
Control groupThe group of subjects who never used protein supplements

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Serum glucose level

    mg/dl

    Measured: 1 day

  2. Serum insulin level

    uU/ml

    Measured: 1 day

  3. Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)

    No unit

    Measured: 1 day

  4. Serum hemoglobine level

    g/dl

    Measured: 1 day

  5. Serum mean platelet volume

    fL

    Measured: 1 day

  6. Serum platelet level

    x10^3/uL

    Measured: 1 day

  7. Serum creatinine level

    mg/dl

    Measured: 1 day

  8. Serum urea level

    mg/dl

    Measured: 1 day

  9. Serum uric acid level

    mg/dl

    Measured: 1 day

  10. Serum aspartate aminotransferase level

    U/L

    Measured: 1 day

  11. Serum alanine aminotransferase level

    U/L

    Measured: 1 day

  12. Serum gama-glutamile transferase level

    U/L

    Measured: 1 day

  13. Serum sodium level

    mmol/L

    Measured: 1 day

  14. Serum potassium level

    mmol/L

    Measured: 1 day

  15. Serum calcium level

    mg/dl

    Measured: 1 day

  16. Serum magnesium level

    mg/dl

    Measured: 1 day

  17. Serum total cholesterol level

    mg/dl

    Measured: 1 day

  18. Serum high-density lipoprotein level

    mg/dl

    Measured: 1 day

  19. Serum low-density lipoprotein level

    mg/dl

    Measured: 1 day

  20. Serum triglyceride level

    mg/dl

    Measured: 1 day

  21. Serum C-reactive protein level

    mg/dl

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2019
  2. Study start15 Mar 2019
  3. Primary completion15 Aug 2019
  4. Study completion20 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
69 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04170036
Sponsor's protocol ID
2019-1-001
Status last verified
Nov 2019
First submitted
15 Nov 2019
Last updated
21 Nov 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The subjects participated in the study do not want this.

Publications

  • Salgueiro RB, Gerlinger-Romero F, Guimaraes-Ferreira L, de Castro Barbosa T, Nunes MT. Exercise training reverses the negative effects of chronic L-arginine supplementation on insulin sensitivity. Life Sci. 2017 Dec 15;191:17-23. doi: 10.1016/j.lfs.2017.10.001. Epub 2017 Oct 7.

    PubMed 28993146

Questions about this trial

What is this clinical trial studying?

An observational study of To Study the Effects of Protein Supplements on Blood Tests, run by Near East University, Turkey at 1 site in Cyprus.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Cyprus. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Serum glucose level (time frame: 1 day). The study lists 21 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04170036, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in